PLx Pharma Inc. Gets Grant for Research into Heart Med for Premature Babies  
3/29/2012 7:29:26 AM

HOUSTON--(BUSINESS WIRE)--PLx Pharma Inc, a Houston-based pharmaceutical company developing a medical discovery made at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded $565,449 for the first year of a potential two-year $1,118,398 grant to conduct research designed to enhance a treatment for premature babies with a common congenital heart defect.